This page provides links to the consultation documents for the NICE evaluation of Spectra Optia Apheresis System for automated red blood cell exchange in patients with sickle cell disease

Consultation on these documents will open on 19 October 2015 at 9.00am and close on 16 November 2015  at 9.00am. NICE would like to receive comments on these documents from anyone who has an interest in the technology, or the area of treatment in general.

Comments should be made via the website or e-mail to MT271SpectraOptia@nice.org.uk

 

Further information about the NICE Medical Technologies    Evaluation programme.


This page was last updated: 19 October 2015